Search results for Legal & Regulatory And Reimbursement

The Influence of Regulatory Requirements and Evolving Reimbursement Models on Health IT Strategy for Payers and Provider...

As with all healthcare topics, the topic of payers and providers is very complex and multifaceted. So today, we are going to narrow our focus down to regulatory requirements and ev...

Radiation Oncology Community Seeking Relief from an Emerging Crisis under 2026 Changes to Medicare Coding and Reimbursem...

Reimbursement Declines Emerge Under 2026 Medicare Changes Stakeholders from the radiation oncology community are reporting substantial declines in aggregate reimbursement during th...

Healthcare & Life Sciences: Drug Pricing Digest - April 2026 #2

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....By: Latham &...

Healthcare & Life Sciences: Drug Pricing Digest - March 2026 #2

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....By: Latham &...

Healthcare & Life Sciences: Drug Pricing Digest - May 2026 #2

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....By: Latham &...

The Compliance Clinic: A cross-disciplinary look at healthcare compliance risk

The Compliance Clinic examines key Medicare, Medicaid, and government enforcement developments across the healthcare industry. Each edition focuses on a specific sector and provide...

McDermott+ Check-Up: April 10, 2026

THIS WEEK’S DOSE Congress wraps up spring recess, turns toward reconciliation. Attention remains on the prospect of a reconciliation 2.0 bill to fund US Immigration and Customs E...

340B Rebate Model: Building Dispute-Ready, Audit-Ready Operations with Better Data and Controls

For more than three decades, the 340B Drug Pricing Program... The post 340B Rebate Model: Building Dispute-Ready, Audit-Ready Operations with Better Data and Controls appeared firs...

McDermott+ Check-Up: May 1, 2026

THIS WEEK’S DOSE House Ways and Means Committee hears from hospital and health system executives. The hearing focused on how to improve healthcare affordability and followed the...

Budget Reconciliation and Health Policy: Understanding the Legislative Process and Where Congress May Go Next

Key Takeaways The FY 2027 budget process is underway, with the president submitting his proposal April 3 and committees beginning hearings the week of April 13. Senate leadership...

The Gold Rush Is Over: Navigating the 2026 Hospice Regulatory Crackdown

For years, the hospice industry saw unprecedented growth, particularly in hubs like Los Angeles County, California, where the number of providers surged over the last decade. But a...

Navigating PBM Reform: Regulatory Changes, Market Shifts, and Practical Guidance for ERISA Fiduciaries

Pharmacy Benefit Manager (“PBM”) arrangements have long relied on rebates with limited transparency into true drug costs. Recent regulatory and market developments represent a shif...

Trending in Telehealth: April 2026

Trending in Telehealth highlights monthly state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists,...

[Video] Podcast - Inside Telehealth's Growth, Regulation and Access

Telehealth innovation succeeds only when compliance discipline matches the pace of growth. In this episode of Counsel That Cares, Holland & Knight healthcare regulatory attorne...

McDermott+ Check-Up: May 15, 2026

THIS WEEK’S DOSE House Energy and Commerce Health Subcommittee advances bipartisan public health bills. Subcommittee members unanimously approved and advanced eight health-relate...

McDermott+ Check-Up: April 17, 2026

This Week's Dose Trump administration officials head to Capitol Hill to testify on FY 2027 budget priorities. US Department of Health and Human Services (HHS) Secretary Kennedy te...

McDermott+ Check-Up: April 24, 2026

THIS WEEK’S DOSE Administration’s FY 2027 budget request hearings continue. US Department of Health and Human Services Secretary Kennedy wrapped up his budget tour on Capitol Hil...

Warning Signs: Potential Congressional Investigations in Healthcare

Few sectors are more consistently in the crosshairs of congressional oversight than healthcare. In the 119th Congress, Republican committee chairs have pursued investigations into...

2026 340B Program Update – 340B Rebate Model RFI Comments Due and Manufacturers Continue Restricting 340B Pricing

Key Takeaways HRSA has extended the deadline for comments on its proposed 340B rebate model pilot program to April 20, 2026. Covered entities have a limited window to submit detai...

Is Your Group Health Plan Ready for a Compliance Audit?

Employer-sponsored group health plans operate at the intersection of multiple federal regulatory frameworks — ERISA, the ACA, COBRA, HIPAA, the Mental Health Parity and Addiction E...

<![CDATA[How are US Regulatory Actions Impacting Pricing?]]>

Budget Reconciliation and Health Policy: Understanding the Legislative Process and Where Congress May Go Next

Key Takeaways - The FY 2027 budget process is underway, with the president submitting his proposal April 3 and committees beginning hearings the week of April 13. Senate leadership...

Health Care Week in Review | Tri-Agencies Release Federal Independent Dispute Resolution (IDR) Operations Final Rule; CM...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and con...

Five Cases Health Care and Life Sciences GCs Should Keep Watching in 2026

In 2026, several federal cases are poised to shape regulatory risk, reimbursement, and False Claims Act exposure, as well as innovation pathways across the health care and life sci...